B-vitamins, homocysteine metabolism and CVD

Proceedings of the Nutrition Society

Volumn 63, Issue 4, 2004, Pages 597-603

  Strain, J J ^a   Dowey, L ^a   Ward, M ^a   Pentieva, K ^a   McNulty, H ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

Folate; Homocysteine; Riboflavin; Vitamin B12; Vitamin B6

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; 5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); AMINO ACID; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; METHIONINE SYNTHASE; PYRIDOXINE; RIBOFLAVIN; VITAMIN B GROUP;

ALLELE; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; DISEASE ASSOCIATION; FOLIC ACID DEFICIENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; HYPERHOMOCYSTEINEMIA; LIFESTYLE; METABOLISM; METHYLATION; NUTRITION; STROKE; VITAMIN SUPPLEMENTATION;

CARBON-NITROGEN LIGASES; CARDIOVASCULAR DISEASES; GENETIC PREDISPOSITION TO DISEASE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; POLYMORPHISM, GENETIC; RISK FACTORS; VITAMIN B COMPLEX; VITAMIN B DEFICIENCY;

EID: 17644408031     PISSN: 00296651     EISSN: None     Source Type: Journal    
DOI: 10.1079/PNS2004390     Document Type: Conference Paper

References (48)

1. Brattstrom L, Wilcken DE, Ohrvik J & Brudin L (1998) Common methylenetrahydrofolate reductase gene mutation leads to hyperhomocysteineamia but not to vascular disease: the result of a meta-analysis. Circulation 98, 2520-2526.
2. Carson NAJ & Neill DW (1962) Metabolic abnormalities detected in a survey of mentally backward individuals in Northern Ireland. Archives of Diseases in Childhood 37, 505-513.
3. Castro R, Rivera I, Struys EA, Jansen EEW, Ravasco P, Camilo ME, Blom HJ, Jakobs C & de Almeida IT (2003) Increased homocysteine and 5-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clinical Chemistry 49, 1292-1296.
4. Chambers JC, Ueland PM, Obeid OA, Wrigley J, Refsum H & Kooner JS (2000) Improved vascular endothelial function after oral B vitamins: An effect mediated through reduced concentrations of free plasma homocysteine. Circulation 102, 2479-2483.
5. Davey-Smith G & Ebrahim S (2003) 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? International Journal of Epidemiology 32, 1-22.
6. Dawson H, Collins G, Pyle R, Deep-Duxit V & Taub DD (2004) The immunoregulatory effects of homocysteine and its intermediates on T-lymphocyte function. Mechanisms of Ageing and Development 125, 107-110.
7. de Bree A, Verschuren WMM, Kromhout D, Kluijtmans LAJ & Blom HJ (2002) Homocysteine determinants and the evidence to what extent homocysteine determines the risk of coronary heart disease. Pharmacological Reviews 54, 599-618.
8. den Heijer M, Brouwer IA, Bos GM, Blom HJ, van der Put NM, Spaans AP, Rosendaal FR, Thomas CM, Haak HL, Wijermans PW & Gerrits WB (1998) Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healthy volunteers. Arteriosclerosis, Thrombosis and Vascular Biology 18, 356-361.
9. Dong C, Yoon W & Goldschmidt-Clemont PJ (2002) DNA methylation and atherosclerosis. Journal of Nutrition 132, 2406S-2409S.
10. Frisco S, Choi SW, Girelli D, Mason JB, Doinikouski GG, Bagley PJ, Olivieri O, Jacques PF, Rosenberg IH, Corrocher R & Selhub J (2002) A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proceedings of the National Academy of Sciences USA 99, 5606-5611.
11. Frosst P, Blom HJ, Milos R, Goyette P, Shepard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA & van den Heuvel LP (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genetics 10, 111-113.
12. Gerritsen T, Vaughn JG & Waisman HA (1962) The identification of homocysteine in the urine. Bichemical and Biophysical Research Communications 9, 493-496.
13. 12 status, particularly holotranscobalamin 11 and methylmalonic acid concentrations, and hyperhomocysteinemia in vegetarians. American Journal of Clinical Nutrition 78, 131-136.
14. Homocysteine Lowering Trialists' Collaboration (1998) Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. British Medical Journal 316, 894-898.
15. Homocysteine Studies Collaboration (2002) Homocysteine and risk of ischaemic heart disease and stroke. Journal of the American Medical Association 288, 2015-2022.
16. Hung C-J, Huang P-C, Lu S-C, Li Y-H, Huang H-B, Lin B-F, Chang S-J & Chou H-F (2002) Plasma homocysteine levels in Taiwanese vegetarians are higher than those of omnivores. Journal of Nutrition 132, 152-158.
17. Hustad S, Ueland PM, Vollset SE, Zhang Y, Bjorke-Monsen A & Schneede J (2000) Riboflavin as a determinant of plasma total homocysteine: effect modification by the methylenetetrahydrofolate reductase C677T polymorphism. Clinical Chemistry 46, 1065-1071.
18. Jacques PF, Kalmbach R, Bagley PJ, Russo GT, Rogers G, Wilson PWF, Rosenberg IH & Selhub J (2002) The relationship between riboflavin and plasma total homocysteine in the Framingham Offspring Cohort is influenced by folate status and the C677T transition in the methylenetetrahydrofolate reductase gene. Journal of Nutrition 132, 283-288.
19. Jacques PF, Selhub J, Bostom AG, Wilson PW & Rosenberg IH (1999) The effect of folic acid fortification on plasma folate and total homocysteine concentrations. New England Journal of Medicine 340, 1449-1454.
20. 6 status after ischemic stroke. Stroke 35, 12-15.
21. 6 but not homocysteine is associated with increased risk of stroke and transient ischemic attack in the era of folic acid grain fortification. Stroke 34, e51-e54.
22. Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Schouten EG & the MTHFR Studies Collaboration Group (2002) MTHFR 677C→T polymorphism and risk of coronary heart disease - A meta analysis. Journal of the American Medical Association 288, 2023-2031.
23. 12 status, and population attributable risk for mild hyperhomocysteinemia among coronary artery disease patients in the era of folic acid-fortified cereal grain flour. Arteriosclerosis, Thrombosis and Vascular Biology 21, 849-851.
24. McCully KS (1969) Vascular pathology of homocysteinamia: implications for the pathogenesis of arteriosclerosis. American Journal of Pathology 56, 111-128.
25. 6 effectively lowers fasting plasma homocysteine in healthy elderly persons who are folate and riboflavin replete. American Journal of Clinical Nutrition 73, 759-764.
26. McKinley MC, McNulty H, McPartlin J, Strain JJ & Scott JM (2002) Effect of riboflavin supplementation on plasma homocysteine in elderly people with low riboflavin status. European Journal of Clinical Nutrition 56, 850-856.
27. McNulty H, Dowey LC, Scott JM, Molloy AM, McAnena LB, Hughes JP, Ward W & Strain JJ (2003) Riboflavin supplementation lowers plasma homocysteine in individuals homozygous for the MTHFR C677T polymorphism. Journal of Inherited Metabolic Disease 26, Suppl. 1, 12 Abstr.
28. McNulty H, McKinley MC, Wilson B, McPartlin J, Strain JJ, Weir DG & Scott JM (2002) Impaired functioning of thermolabile methylenetetrahydrofolate reductase is dependent on riboflavin status: implications for riboflavin requirements. American Journal of Clinical Nutrition 76, 436-441.
29. Mangoni AA & Jackson SHD (2002) Homocysteine and cardiovascular disease: current evidence and future prospects. American Journal of Medicine 112, 556-565.
30. Mann NJ, Li D, Sinclair AJ, Dudman NPB, Guo XW, Elsworth GR, Wilson AK & Felly FD (1999) The effect of diet on plasma homocysteine concentrations in healthy male subjects. European Journal of Clinical Nutrition 53, 895-899.
31. Nygard O, Refsum H, Ueland PM & Vollset SE (1998) Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study. American Journal of Clinical Nutrition 67, 263-270.
32. Olthof MR, van Vliet T, Boelsma E & Verhoef P (2003) Low-dose betaine supplementation leads to immediate and long term lowering of plasma homocysteine in healthy men and women. Journal of Nutrition 133, 4135-4138.
33. 12 in reduction of risk of vascular disease. Lancet 359, 227-228.
34. 6 from diet and supplements in relation to risk of coronary heart disease among women. Journal of the American Medical Association 279, 359-364.
35. Robinson K (2000) Homocysteine, B vitamins, and risk of cardiovascular disease. Heart 83, 127-130.
36. Schnyder G, Rammer Y, Roffi M, Pin R & Hess OM (2002) Plasma homocysteine levels and late outcome after coronary angioplasty. Journal of the American College of Cardiology 40, 1769-1776.
37. Schnyder G, Roffi M, Pin R, Flammer Y, Lange H, Eberli FR, Meier B, Turi ZG & Hess OM (2001) Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. New England Journal of Medicine 345, 1593-1600.
38. Schwahn BC, Chen ZT, Laryea MD, Wendel U, Lussier-Cacan S, Genest J, Mar MH, Zeisel SH, Castro C, Garrow T & Rozen R (2003) Homocysteine-betaine interactions in a murine model of 5,10-methylenetetrahydrofolate reductase deficiency. FASEB Journal 17, U163-U187.
39. 12. European Journal of Clinical Nutrition 51, Suppl. 1, S49-S53.
40. Stern LL, Shane B, Bagley PJ, Nadeau M, Shih V & Selhub J (2003) Combined marginal folate and riboflavin status affect homocysteine methylation in cultured immortalized lymphocytes from persons homozygous for the MTHFR C677T mutation. Journal of Nutrition 133, 2716-2720.
41. Tighe P, Ward M, McNulty H, Finnegan O, Strain JJ, Dunne A, Molloy AM & Scott JM (2004) Plasma homocysteine response to folic acid intervention in ischaemic heart disease patients: implications for food fortification policy. Proceedings of the Nutrition Society 63, (In the Press).
42. Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ, Slides EG, Wong C-H & Stampfer M (2004) Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction and death. Journal of the American Medical Association 291, 565-575.
43. Ubbink JB (1994) Vitamin nutrition status and homocysteine: an atherogenic risk factor. Nutrition Reviews 52, 383-387.
44. Van Oort FVA, Melse-Boostra A, Brouwer IA, Clarke R, West CE, Katan MB & Verhoef P (2003) Folic acid and reduction of plasma homocysteine concentrations in older adults: a dose-response study. American Journal of Clinical Nutrition 77, 1318-1323.
45. Wald DS, Bishop L, Wald NJ, Law M, Hennessy E, Weir D, McPartlin J & Scott J (2001) Randomized trial of folic acid supplementation and serum homocysteine levels. Archives of Internal Medicine 161, 695-700.
46. Wald DS, Law M & Morris JK (2002) Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. British Medical Journal 325, 1202-1206.
47. Ward M, McNulty H, McPartlin J, Strain JJ, Weir DG & Scott JM (1997) Plasma homocysteine, a risk factor for cardiovascular disease, is lowered by physiological doses of folic acid. Quarterly Journal of Medicine 90, 519-524.
48. Yamada K, Chen Z, Rozen R & Matthews RG (2001) Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase. Nature Structural Biology 6, 359-365.